| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Health Catalyst, Inc Common Stock$2.31
-0.68 (-28.45%)
Market Cap
170.70 M
EPS
-3.59
P/E Ratio
-
Value Trade
472.65 K
SEC Financials
Q1 2026Dilution Risk
Revenue
70.76 M
R&D Expenses
9.78 M
Operating CF
18.51 M
Total Assets
412.20 M
Total Liabilities
274.06 M
Equity
138.15 M
11.06 %
Week
1.76 %
1 Month
45.28 %
3 Month
10.53 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
108.82 M
Monthly Burn
-
Runway
-
Burn Trend
StableSEC Filing
May 11, 2026
Overview
Volume
2.25 M
52 Week Range
0.96 - 3.88
% held by Insiders
17.16 %
% held by Institutions
70.22 %
Enterprise Value
216.86 M
Total Shares
73.89 M
Short %
5.95 %
Float Shares
50.84 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in HCAT
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
HCAT Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-HCAT
Aug 6, 2026▼ -28.5%today
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Health Catalyst has successfully completed the sale of Vitalware to Med-Metrix, allowing the company to retire its credit facility debt. This strategic move enables Health Catalyst to concentrate on its core technology aimed at improving health system performance. The transaction, valued at $147 million, is expected to enhance the company's financial flexibility and support its investment in AI-driven healthcare intelligence products.
Read more →-HCAT
Jul 28, 2026Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
Health Catalyst, Inc. will announce its second quarter 2026 operating results on August 6, 2026, after market close. A conference call will follow at 5:00 pm ET to discuss the results. Participants can join via phone or through a live audio webcast. The company emphasizes its role in improving health systems through data-driven actions.
Read more →-HCAT
Jul 28, 2026MidCap Advisors Advises Leading Midwest Psychiatric Care Provider in Its Acquisition by Health Catalyst Capital
MidCap Advisors has successfully advised a Midwest psychiatric care provider in its acquisition by Health Catalyst Capital. This partnership aims to expand the provider's reach and enhance care quality for elderly and disabled adults. The acquisition is expected to leverage HCC's healthcare network and operational expertise to foster growth.
Read more →-HCAT
Jun 16, 2026Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst, a healthcare intelligence company, will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference on June 24, 2026. CEO Ben Albert will lead a panel discussion titled 'AI ROI in Healthcare: Real vs Hype Debate.' The event highlights Health Catalyst's commitment to improving health systems through AI technology.
Read more →-HCAT
Jun 4, 2026▲ +45.9%on this news
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation Transaction reflects a sharper focus on AI and core technology net proceeds expected to strengthen balance sheet and provide fin
Health Catalyst, Inc. has announced an agreement to divest its mid-revenue cycle unit, Vitalware, to Med-Metrix for $147 million in cash. This move aligns with Health Catalyst's strategy to concentrate on its core technology and AI investments aimed at enhancing health systems' performance. The proceeds from the sale will be utilized to pay off existing debts, which is expected to improve the company's financial standing. The transaction is anticipated to finalize in 2026, pending certain regulatory approval conditions.
Read more →-HCAT
May 11, 2026▼ -9.2%on this news· ran to -23% by day 3
Health Catalyst Reports First Quarter 2026 Results
Health Catalyst, Inc. reported its financial results for Q1 2026, showing a revenue decline of 11% compared to the previous year. Despite this dip, the company announced that revenue and adjusted EBITDA exceeded expectations, reflecting efforts in its strategic reset. The net loss has significantly increased, which the company attributed to several uncontrollable factors. Looking ahead, Health Catalyst provided revenue guidance for Q2 2026 and the full year, signaling cautious optimism amid financial challenges.
Read more →-HCAT
May 1, 2026▲ +16%on this news
Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026
Health Catalyst, Inc. will announce its first quarter 2026 operating results on May 11, 2026, after market close. The company will also host a conference call at 5:00 pm ET to review these results. Participants can access the call via phone or a live audio webcast, with a replay available for 90 days.
Read more →-HCAT
Apr 30, 2026Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase
Health Catalyst announced the appointment of Steve Nelson, current President of Aetna, to its Board of Directors, effective May 1, 2026. This appointment follows recent leadership changes, including the naming of Ben Albert as CEO. Nelson brings significant experience from various leadership roles in healthcare, which Health Catalyst views as essential for executing their strategy aimed at improving health system performance. Nelson expressed his enthusiasm for joining the company during a pivotal time in the healthcare landscape.
Read more →-HCAT
Mar 13, 2026▼ -26.3%on this news
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
Health Catalyst reported strong financial results for Q4 and the full year of 2025, with total revenue of $311.1 million and an Adjusted EBITDA of $41.4 million. CEO Ben Albert highlighted both opportunities and areas for improvement as the company focuses on long-term success. However, the company is not providing guidance for 2026 due to an ongoing internal strategic review.
Read more →-HCAT
Mar 2, 2026Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026
Health Catalyst, Inc. will announce its fourth quarter and year-end 2025 operating results on March 12, 2026. Following the announcement, the company will host a conference call at 5:00 pm ET to discuss the results. Participants can access the call via phone or a live audio webcast, with a replay available afterward.
Read more →-HCAT
Feb 18, 2026Health Catalyst Appoints Ben Albert as Chief Executive Officer Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare Health Catalyst Board to be Red
Health Catalyst has appointed Ben Albert as the new Chief Executive Officer, effective February 12, 2026. Albert, who previously served as the President and COO, aims to enhance operational efficiency and clinical quality while improving consumer experience. The board of directors will also be reduced to five members, including Albert, following the departure of several directors. This leadership shift is part of Health Catalyst's strategy to align resources with high-return priorities and support improved financial performance.
Read more →-HCAT
Dec 2, 2025▼ -5.2%on this news
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Health Catalyst, Inc. has appointed Matt Arens, CEO and Founder of First Light Asset Management, to its board of directors, effective immediately. First Light is the largest shareholder of Health Catalyst, owning over 13 million shares. Arens brings nearly 30 years of investment experience, particularly in healthcare, and has a strong track record in capital markets. His appointment is expected to provide valuable insights for the company as it pursues growth and shareholder value. In related news, Matthew Kolb will not seek re-election to the board at the 2026 annual meeting.
Read more →-HCAT
Nov 10, 2025Health Catalyst Reports Third Quarter 2025 Results
Health Catalyst reported its financial results for the third quarter of 2025, highlighting a total revenue of $76.3 million and an Adjusted EBITDA of $12 million. Both measures surpassed the company’s guidance for the quarter. However, the company also reported a net loss of $22.2 million, which represents a significant increase from the prior year. Despite the losses, Health Catalyst remains optimistic about its full-year projections for 2025.
Read more →-HCAT
Sep 10, 2025Health Catalyst Appoints Ben Albert to the Role of President and COO Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement Salt Lake City, UT
Health Catalyst has appointed Ben Albert as its new President and COO, effective immediately. Albert, who previously led Upfront Healthcare Services, will provide pivotal day-to-day leadership as the company prepares for long-term success. His appointment is seen as a critical part of the leadership transition following CEO Dan Burton's planned retirement in June 2026. The board and existing leadership express confidence in Albert's ability to drive the company forward in its mission of improving healthcare outcomes.
Read more →-HCAT
Aug 7, 2025Health Catalyst Reports Second Quarter 2025 Results
Health Catalyst, Inc. reported its second-quarter financial results for 2025, with revenues of $80.7 million surpassing guidance, and a notable increase in Adjusted EBITDA to $9.3 million. The company is also dealing with a significant net loss of $40.978 million, marking a 203% increase compared to the prior year. CEO Dan Burton announced plans to retire in June 2026, after 15 years in the role, which may lead to leadership transitions. Despite these challenges, Health Catalyst offers optimistic financial guidance for the future.
Read more →-HCAT
May 7, 2025Health Catalyst Reports First Quarter 2025 Results
Health Catalyst, Inc. reported strong financial results for Q1 2025, achieving total revenue of $79.4 million and an Adjusted EBITDA of $6.3 million, both exceeding expectations. The company also added 10 new Platform Clients, reinforcing its growth strategy. Despite the positive performance, the company reported a net loss of $23.7 million, up from the previous year, and a decline in gross margin. Forward-looking guidance anticipates continued revenue growth, projecting $80.5 million in Q2 and approximately $335 million for the full year.
Read more →-HCAT
Feb 26, 2025Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Health Catalyst has reported solid financial results for Q4 and full-year 2024, with total revenue reaching $307 million and Adjusted EBITDA at $26 million. The Technology segment demonstrated a year-over-year growth of 10%, and the company anticipates further acceleration in growth for 2025. Changes in leadership, including the addition of Dr. Jill Hoggard Green to the Board of Directors and the promotion of key executives, are indicative of the company's strategic focus. However, the firm still faced a net loss despite these improvements, raising questions about long-term profitability.
Read more →-HCAT
Jan 13, 2025▼ -5.8%on this news· ran to -20% by day 3
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services
Health Catalyst has announced the signing of a definitive agreement to acquire Upfront Healthcare Services, aiming to enhance its patient engagement offerings. The transaction is set to close in the first quarter of 2025 and will combine Upfront's patient acquisition expertise with Health Catalyst's current services. This move is expected to support healthcare providers in guiding and engaging patients effectively. Health Catalyst plans to finance the acquisition through cash and stock.
Read more →-HCAT
Nov 6, 2024▲ +6.3%on this news
Health Catalyst Reports Third Quarter 2024 Results
Health Catalyst, Inc. reported strong financial results for Q3 2024, with total revenue of $76.4 million and an Adjusted EBITDA of $7.3 million, both exceeding the company's expectations. The CEO highlighted the commitment to profitable growth and expressed optimism regarding future bookings and quarterly guidance increases. While the company saw improvements in revenue and EBITDA, it continues to face a net loss of $14.7 million, suggesting challenges ahead. The company also raised its Adjusted EBITDA guidance for 2024 by $1 million, showcasing a positive outlook despite ongoing financial hurdles.
Read more →-HCAT
Aug 7, 2024▼ -7.6%on this news· ran to +27% by day 1
Health Catalyst Reports Second Quarter 2024 Results
Health Catalyst, Inc. reported its financial results for the second quarter of 2024, achieving total revenue of $75.9 million and an Adjusted EBITDA of $7.5 million. The company noted a significant increase in new Platform Subscription Clients, surpassing the number signed in all of 2023. Despite these positive results, Health Catalyst reported a net loss of $13.5 million and acknowledged potential risks from macroeconomic conditions and regulatory changes. The company provided guidance for continued growth in the third quarter and full year of 2024.
Read more →-HCAT
Jul 18, 2024▼ -5.2%on this news
Health Catalyst Announces New Credit Facility for up to $225,000,000 Salt Lake City, Utah
Health Catalyst has announced a new five-year credit facility of up to $225 million, which includes an initial loan of $125 million and a delayed draw loan facility of $100 million. The funding aims to refinance existing convertible notes and support general corporate purposes, offering the company the flexibility for organic and inorganic growth. This financing is seen as a crucial step in enhancing the company's position in the healthcare analytics market. Health Catalyst expresses optimism about this partnership with Silver Point Finance, reinforcing their strategy for future development.
Read more →-HCAT
May 9, 2024Health Catalyst Reports First Quarter 2024 Results
Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million, reflecting a 1% increase year-over-year. The company achieved an Adjusted EBITDA of $3.4 million, although this represents a 19% decline from the previous year. Notably, the company's net loss improved significantly by 38%. Health Catalyst has also reaffirmed its revenue and EBITDA guidance for the full year of 2024.
Read more →-HCAT
Feb 22, 2024▼ -7.1%on this news
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
Health Catalyst reported strong financial results for the fourth quarter and full year of 2023, with total revenue surpassing guidance. The company indicated a positive outlook for 2024, forecasting significant growth in Adjusted EBITDA. Leadership changes were also announced, with a focus on enhancing operational performance. Despite progress, Health Catalyst continues to report losses from operations, raising concerns about profitability.
Read more →-HCAT
Nov 2, 2023Health Catalyst Reports Third Quarter 2023 Results
Health Catalyst, Inc. reported its third quarter 2023 results, showing a total revenue of $73.8 million and an Adjusted EBITDA of $2.0 million, both exceeding expectations. The company raised its full-year revenue guidance, supported by consistent bookings aligned with their forecasts. CEO Dan Burton highlighted strong team member engagement levels, ranking in the 94th percentile, while also noting a decrease in adjusted professional services gross profit. These results reflect both growth opportunities and some ongoing financial challenges.
Read more →-HCAT
Oct 27, 2023Health Catalyst Reports Third Quarter 2023 Preliminary Results
Health Catalyst, Inc. has reported preliminary financial results for Q3 2023, highlighting total revenue of $73.8 million and adjusted EBITDA of $2.0 million, both surpassing guidance expectations. The company has updated its guidance for full-year revenue, indicating a positive outlook. However, it continues to incur a net loss of $22.0 million and faces challenges such as a notable decline in adjusted professional services gross margin. The finalized financial outcomes will be released on November 2, 2023.
Read more →-HCAT
Aug 8, 2023Health Catalyst Reports Second Quarter 2023 Results
Health Catalyst, Inc. reported its second quarter results for 2023, highlighting total revenues of $73.2 million, surpassing mid-point guidance. The company's Adjusted EBITDA reached $3.5 million, up 76% year over year, prompting an increase in its full-year guidance for both revenue and EBITDA. Despite these positive financial trends, Health Catalyst noted a net loss of $32.6 million and a decrease in their adjusted professional services gross margin. Overall, the results were encouraging, showcasing strong pipeline growth and bookings performance.
Read more →-HCAT
May 9, 2023Health Catalyst Reports First Quarter 2023 Results
Health Catalyst, Inc. reported its financial results for Q1 2023, achieving strong performance that exceeded revenue and Adjusted EBITDA guidance. The company expanded its partnership with Allina Health, which will increase recurring annual revenue significantly. However, the company also reported losses from operations and net losses that rose compared to the previous year, highlighting ongoing financial challenges. Despite these challenges, Health Catalyst remains optimistic about continued growth and partnerships in the future.
Read more →-HCAT
Feb 28, 2023Health Catalyst Reports Fourth Quarter and Year End 2022 Results
Health Catalyst reported positive financial results for Q4 and full-year 2022, exceeding revenue and Adjusted EBITDA guidance. CEO Dan Burton emphasized strong business performance despite lower annual growth expectations. The company announced the appointment of Matthew Kolb to its Board and acknowledged a significant investment by Carle Health, indicating strong financial support. However, the company faced challenges with professional services revenue retention due to adverse macroeconomic pressures.
Read more →-HCAT
Feb 28, 2023Innovative Healthcare Executive and Carle Health COO Matthew Kolb Joins Health Catalyst Board of Directors Carle Health Becomes Health Catalyst Shareholder Salt Lake City, UT
Health Catalyst has appointed Matthew Kolb, COO of Carle Health, to its Board of Directors effective July 1, 2023. This move underscores a strengthened partnership, as Carle Health also announced its decision to become a significant shareholder in Health Catalyst. The collaboration aims to enhance data-informed healthcare improvements and analytics capabilities, beneficial for both organizations. Kolb's leadership experience is expected to provide valuable insights into addressing healthcare challenges.
Read more →-HCAT
Jan 6, 2023▲ +5.5%on this news
Health Catalyst Announces New, External Leadership Assignment for Paul Horstmeier Salt Lake City, UT
Health Catalyst has announced that Paul Horstmeier, COO, will transition to a Senior Advisor role while serving as Mission President of the Puerto Rico San Juan Mission. This leadership assignment will begin in late June 2023 and will last for three years. His contributions over the past 11 years have been recognized as significant, and Health Catalyst is committed to a smooth transition of responsibilities. Upon completion of his mission, Horstmeier is expected to return to his full-time position at the company.
Read more →-HCAT
Nov 8, 2022▼ -5.8%on this news· ran to +43% by day 3
Health Catalyst Reports Third Quarter 2022 Results
Health Catalyst Reports Third Quarter 2022 Results SALT LAKE CITY, UT, November 8, 2022 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the
Read more →-HCAT
Sep 7, 2022Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas Announces Appointments of Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as Chief Marketing Officer, and Dave Ross as C
Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas Announces Appointments of Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as Chief Marketing Officer, and Dave Ross as Chief Technology Officer. Salt Lake City, UT - September 7,
Read more →-HCAT
Aug 4, 2022Health Catalyst Announces $40 Million Share Repurchase Program
Health Catalyst Announces $40 Million Share Repurchase Program SALT LAKE CITY, UT, August 4, 2022 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that its board
Read more →-HCAT
Aug 4, 2022Health Catalyst Reports Second Quarter 2022 Results
Health Catalyst Reports Second Quarter 2022 Results SALT LAKE CITY, UT, August 4, 2022 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the
Read more →-HCAT
May 10, 2022Health Catalyst Reports First Quarter 2022 Results
Health Catalyst Reports First Quarter 2022 Results SALT LAKE CITY, UT, May 10, 2022 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the qua
Read more →-HCAT
Mar 1, 2022Health Catalyst Reports Fourth Quarter and Year End 2021 Results
Health Catalyst Reports Fourth Quarter and Year End 2021 Results SOUTH JORDAN, UT, March 1, 2022 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial result
Read more →-HCAT
Nov 9, 2021Health Catalyst Reports Third Quarter 2021 Results
Health Catalyst Reports Third Quarter 2021 Results SALT LAKE CITY, UT, November 9, 2021 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the
Read more →-HCAT
Aug 5, 2021Health Catalyst Reports Second Quarter 2021 Results
Health Catalyst Reports Second Quarter 2021 Results SALT LAKE CITY, UT, August 5, 2021 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the
Read more →-HCAT
Jun 24, 2021Health Catalyst Announces Agreement to Acquire Twistle Twistle, a Patient Engagement SaaS Technology Solution, to Enhance Health Catalyst's Population Health Offering and Enable More Comprehensive Support for Organizatio
Health Catalyst Announces Agreement to Acquire Twistle Twistle, a Patient Engagement SaaS Technology Solution, to Enhance Health Catalyst's Population Health Offering and Enable More Comprehensive Support for Organizations Transitioning to Population Health Care Models Salt Lak
Read more →-HCAT
May 6, 2021Health Catalyst Reports First Quarter 2021 Results
Health Catalyst Reports First Quarter 2021 Results SALT LAKE CITY, UT, May 6, 2021 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quar
Read more →-HCAT
Feb 25, 2021Health Catalyst Reports Fourth Quarter and Year End 2020 Results
Health Catalyst Reports Fourth Quarter and Year End 2020 Results SOUTH JORDAN, UT, February 25, 2021 - Health Catalyst, Inc. ( Health Catalyst, Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial re
Read more →-HCAT
Nov 10, 2020Health Catalyst Reports Third Quarter 2020 Results
Health Catalyst Reports Third Quarter 2020 Results SALT LAKE CITY, UT, November 10, 2020 - Health Catalyst, Inc. (Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended Se
Read more →-HCAT
Sep 8, 2020Health Catalyst Completes Hosting of the Largest Ever Healthcare Analytics Summit and Announces the Close of the Vitalware Acquisition Company Moves Forward with Co-Founder's Return and Leadership Transitions
Health Catalyst Completes Hosting of the Largest Ever Healthcare Analytics Summit and Announces the Close of the Vitalware Acquisition Company Moves Forward with Co-Founder's Return and Leadership Transitions SALT LAKE CITY, UT, September 8, 2020 - The board of directors (the "
Read more →-HCAT
Aug 11, 2020Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution
Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution SALT LAKE CITY, UT, August 11, 2020 - Health Catalyst, Inc. ("Health Catalyst," Nasdaq HCAT), a leading provider of data and analytics technology and
Read more →-HCAT
Aug 11, 2020Health Catalyst Reports Second Quarter 2020 Results
Health Catalyst Reports Second Quarter 2020 Results SALT LAKE CITY, UT, August 11, 2020 - Health Catalyst, Inc. (Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended Jun
Read more →-HCAT
May 12, 2020Health Catalyst Reports First Quarter 2020 Results
Health Catalyst Reports First Quarter 2020 Results SALT LAKE CITY, UT, May 12, 2020 - Health Catalyst, Inc. (Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 3
Read more →-HCAT
May 12, 2020Mark Templeton Appointed to Health Catalyst Board of Directors
Mark Templeton Appointed to Health Catalyst Board of Directors SALT LAKE CITY, UT, May 12, 2020 - The board of directors (the "Board") of Health Catalyst, Inc. ("Health Catalyst," Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organi
Read more →-HCAT
Apr 9, 2020About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare impr
Health Catalyst, Inc. Announces Proposed Offering of $175 Million Convertible Senior Notes SALT LAKE CITY, UT, - April 8, 2020 - Health Catalyst, Inc. (Nasdaq HCAT) (the "Company" or "Health Catalyst") announced today that it intends to offer, subject to market conditions and ot
Read more →-HCAT
Feb 27, 2020Health Catalyst Reports Fourth Quarter and Year End 2019 Results
Health Catalyst Reports Fourth Quarter and Year End 2019 Results SALT LAKE CITY, UT, February 27, 2020 - Health Catalyst, Inc. (Nasdaq HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the qu
Read more →-HCAT
Nov 12, 2019Experienced Technology Executives Julie Larson-Green and S. Dawn Smith appointed to Health Catalyst Board of Directors
Experienced Technology Executives Julie Larson-Green and S. Dawn Smith appointed to Health Catalyst Board of Directors SALT LAKE CITY, UT, November 12, 2019 - The board of directors (the "Board") of Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of
Read more →-HCAT
Nov 12, 2019Health Catalyst Reports Third Quarter 2019 Results
Health Catalyst Reports Third Quarter 2019 Results SALT LAKE CITY, UT, November 12, 2019 - Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the third quarter e
Read more →-HCAT
Aug 22, 2019Health Catalyst Reports Second Quarter 2019 Results
Health Catalyst Reports Second Quarter 2019 Results SALT LAKE CITY, UT, August 22, 2019 - Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the second quarter e
Read more →Competitive Position
How HCAT ranks across every disease it competes inCompetitive Position is a premium feature
See how HCAT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial